Clinical trial
A Phase 1/2 Study of Repeated Subcutaneous E6011 Administration in Japanese Subjects With Rheumatoid Arthritis
NCT02196558 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Study of Repeated Subcutaneous E6011 Administration in Japanese Subjects With Rheumatoid Arthritis
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 26, 2014
- Completion date
- July 13, 2017
- Enrollment
- 53 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.